data13F

KURA – Kura Oncology Inc

Held by 1 of 60 tracked investors in their latest 13F filing · 0 counted on Most owned (narrow-view filings excluded)

Investors holding1
Combined shares42,940
Combined reported value$460K

KURA chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Paul Tudor Jones narrow view 0.00 Reduced 1.3%42,940$460KQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Reduced 1.3%42,9400.00
Q1 2026Polen Capital Closed00.00
Q1 2026Paul Tudor Jones narrow view Reduced 1.1%43,5200.00
Q4 2025Polen Capital New90,8470.00
Q4 2025Paul Tudor Jones narrow view New44,0200.00

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q4 2025Polen Capital New90,8470.00
Q4 2025Paul Tudor Jones narrow view New44,0200.00

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Reduced 1.3%42,9400.00
Q1 2026Polen Capital Closed00.00
Q1 2026Paul Tudor Jones narrow view Reduced 1.1%43,5200.00

History

2 peakQ3 2026: 1 tracked investors
Q2 2019: 1 tracked investorsQ4 2020: 1 tracked investorsQ4 2021: 1 tracked investorsQ2 2023: 1 tracked investorsQ4 2024: 1 tracked investorsQ4 2025: 2 tracked investorsQ1 2026: 1 tracked investorsQ2 2026: 1 tracked investorsQ3 2026: 1 tracked investors
20192026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Paul Tudor Jones42.9K43.5K43.5K44.0K–––38.8K

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).